Stay updated on Cadonilimab & Regorafenib Combo in Hepatocellular Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Cadonilimab & Regorafenib Combo in Hepatocellular Carcinoma Clinical Trial page.

Latest updates to the Cadonilimab & Regorafenib Combo in Hepatocellular Carcinoma Clinical Trial page
- CheckyesterdayChange DetectedA new revision entry (v3.6.5) was added to the study record history, and the previous revision (v3.6.4) was removed from the current listing, indicating a platform version update rather than content changes.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedA new site release version, v3.6.4, is added to the record history, replacing the previous release v3.6.3.SummaryDifference0.1%

- Check22 days agoNo Change Detected
- Check36 days agoChange DetectedThe record history now shows a new revision tag, v3.6.3, while the previous tag v3.6.2 is removed. This indicates an update to the study record’s version, rather than a change to the study’s content or eligibility.SummaryDifference0.1%

- Check44 days agoChange DetectedThe page’s Revision tag was updated from v3.6.0 to v3.6.2, signaling a backend software release. This update underpins the page without changing the displayed study information.SummaryDifference0.1%

- Check58 days agoChange DetectedRecruitment status updated to 'No longer looking for participants' and the record shows a new revision version, v3.6.0, reflecting the updated history entry.SummaryDifference0.5%

- Check65 days agoChange DetectedThe history for the record now shows Revision: v3.5.5, replacing the previous v3.5.4, indicating a software update to the page rendering.SummaryDifference0.1%

Stay in the know with updates to Cadonilimab & Regorafenib Combo in Hepatocellular Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cadonilimab & Regorafenib Combo in Hepatocellular Carcinoma Clinical Trial page.